Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Argos Therapeutics Inc (NASDAQ:ARGS)

0.185
Delayed Data
As of 4:00pm ET
 +0.01 / +5.71%
Today’s Change
0.17
Today|||52-Week Range
5.68
-96.22%
Year-to-Date
No recent news for Argos Therapeutics Inc.

Today’s Trading

Previous close0.18
Today’s open0.18
Day’s range0.18 - 0.19
Volume3,610,809
Average volume (3 months)1,863,190
Market cap$9.6M
Dividend yield--
Data as of 4:00pm ET, 09/19/2017

Growth & Valuation

Earnings growth (last year)+54.64%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+82.41%
P/E ratioNM
Price/Sales165.87
Price/Book1.17

Competitors

 Today’s
change
Today’s
% change
HEBHemispherx Biopharma...-0.01-3.03%
RPRXRepros Therapeutics ...-0.01-1.74%
ITUSITUS Corp+0.62+48.44%
ACHVAchieve Life Science...-0.14-4.86%
Data as of 4:56pm ET, 09/19/2017

Financials

Next reporting dateNovember 13, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$945.5K
Annual profit (last year)-$53.0M
Net profit margin-5,608.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey D. Abbey
CFO, Vice President &
Investor Relations Contact
Richard D. Katz
Corporate headquarters
Durham, North Carolina

Forecasts